Entries by sopnz

The ELSA Study

The ELSA study launched nationally on World Diabetes Day in November 2022. Within 24 hours, over 1000 children were signed-up to the study! By February 2023, we have sent over 3000 home-testing kits out to families and have analysed over 1000 kits so far. The next phase of the study is to disseminate to schools […]

First Treatment to Delay Type 1 Diabetes Licensed in the US

On 17/11/22 teplizumab was approved by the US Food and Drug Administration (FDA) as the first ever treatment indicated to delay the onset of stage 3 type 1 diabetes. This is the biggest treatment breakthrough for the condition since the discovery of insulin 100 years ago. Although teplizumab is not approved in the UK yet, […]

Mahn’s story: taking part in immunotherapy research

An 11 year old’s story of taking part in immunotherapy research: Mahn was diagnosed with type 1 diabetes in May 2020. His parents Sharon and Harj were determined to get him onto a clinical trial testing a new treatment called immunotherapy, which hopes to slow the immune attack behind type 1 diabetes. Please click the […]

Type 1 Diabetes Breakthrough

Scientists and researchers are hoping to slow down the progression or prevent type one diabetes with immunotherapy treatments. This thought-provoking article from  DUK’s Balance magazine explains how immunotherapy can help fight type 1 diabetes. Delaying type 1 diabetes: an exciting breakthrough has been made by scientists in the trial of an immunotherapy drug that has […]

Multi-peptide Trial Aims to ‘Stall’ Type 1 Diabetes

Researchers at King’s College London and Guy’s and St Thomas’ hospital look into the possibility of slowing the progression of type 1 diabetes. Link to news article with video:  http://www.bbc.co.uk/news/health-35847271

Pioneering Research for Type 1 Diabetes

MonoPepT1De clinical trial for type 1 diabetes treatment shows promising results. Link to news article: http://www.bbc.co.uk/news/health-40876438 Link to publication of results: http://stm.sciencemag.org/content/9/402/eaaf7779.full